» Articles » PMID: 30468269

Characterization of the Chemical Constituents in Hongjingtian Injection by Liquid Chromatography Quadrupole Time-of-flight Mass Spectrometry

Overview
Publisher Wiley
Specialties Biology
Chemistry
Date 2018 Nov 24
PMID 30468269
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Hongjingtian injection is made from Rhodiola wallichiana and used in the treatment of stable angina pectoris associated with coronary heart disease. In this study, the chemical constituents in Hongjingtian injection were comprehensively studied using liquid chromatography quadrupole time-of-flight mass spectrometry. A total of 49 compounds were identified or assumed, including 10 organic acids, nine phenylethanoids, 10 phenylpropanoids, two flavonoid glycosides, seven monoterpene glycosides, seven octylglycosides and four other types of compounds. The structures of seven compounds were confirmed by comparing their retention times, MS and UV spectra with the corresponding authentic standards. Amongst the 49 compounds, 35 were firstly found in R. wallichiana, while they have been reported in other species of the genus Rhodiola, including Rhodiola crenulata, Rhodiola sacra, Rhodiola rosea and Rhodiola kirilowii. The possible fragmentation pathways in the mass spectrometry of the major types of compounds are proposed and summarized. Our study demonstrates a rapid method for characterizing the chemical constituents present in the Hongjingtian injection, which could also be applied to the identification of chemical constituents in other TCM formulae containing R. wallichiana.

Citing Articles

Investigating the multitarget pharmacological mechanism of var. acting on angina pectoris using combined network pharmacology and molecular docking.

Zhang H, Zhuang X, Li Z, Wang X J Thorac Dis. 2024; 16(2):1350-1367.

PMID: 38505080 PMC: 10944760. DOI: 10.21037/jtd-23-1891.


Dazhu Hongjingtian Injection for Ischemic Stroke: Protocol for a Prospective, Multicenter Observational Study.

Che Q, Song T, Liang N, Guo J, Chen Z, Liu X JMIR Res Protoc. 2023; 12:e52447.

PMID: 38133909 PMC: 10770785. DOI: 10.2196/52447.


Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges.

Huajuan J, Xulong H, Bin X, Yue W, Yongfeng Z, Chaoxiang R Front Pharmacol. 2023; 14:1038906.

PMID: 36909150 PMC: 9998719. DOI: 10.3389/fphar.2023.1038906.


Identifying the mechanisms and molecular targets of Hongjingtian injection on treatment of TGFβ1-induced HK-2 cells: coupling network pharmacology with experimental verification.

Sun G, Jiao M, Cui Y, Liang X, Liang X, Zhang S Ann Transl Med. 2023; 10(24):1329.

PMID: 36660701 PMC: 9843345. DOI: 10.21037/atm-22-5035.


Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS.

Fu S, Cheng R, Deng Z, Liu T J Pharm Anal. 2022; 11(6):709-716.

PMID: 35028175 PMC: 8740115. DOI: 10.1016/j.jpha.2021.01.004.